NAOS SIGNED
a disruptive implantable neurostimulator for the treatment of epilepsy
Total Cost €
0EC-Contrib. €
0Partnership
0Views
0NAOS project word cloud
Explore the words cloud of the NAOS project. It provides you a very rough idea of what is the project "NAOS" about.
Project "NAOS" data sheet
The following table provides information about the project.
| Coordinator |
SYNERGIA MEDICAL
Organization address contact info |
| Coordinator Country | Belgium [BE] |
| Total cost | 71˙429 € |
| EC max contribution | 50˙000 € (70%) |
| Programme |
1. H2020-EU.3. (PRIORITY 'Societal challenges) 2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs) 3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies) |
| Code Call | H2020-SMEInst-2018-2020-1 |
| Funding Scheme | SME-1 |
| Starting year | 2019 |
| Duration (year-month-day) | from 2019-07-01 to 2019-11-30 |
Partnership
Take a look of project's partnership.
| # | ||||
|---|---|---|---|---|
| 1 | SYNERGIA MEDICAL | BE (MONT-SAINT-GUIBERT) | coordinator | 50˙000.00 |
Map
Project objective
The objective of this innovation project is to develop a disruptive implantable neurostimulator for the treatment of epilepsy with the goal to place it on the market by 2021.
Neurostimulation is a $4.7 billion market and one of the fastest-growing areas of medicine, that has been approved for the treatment of several neurological disorders. Among these, epilepsy is the most frequent nervous system disease. Of the 50 million people suffering from epilepsy, with 3.7 million in Europe, approximately one third of them are resistant to medication but respond well to the neurostimulation.
Neurostimulators are small implanted devices stimulating nerves or brain tissue. The innovative aspects of the project are based on a Synergia Medical’s patented concept and consists in replacing wires by optical fibres.
The innovation will improve the traditional therapy and brings the main following competitive advantages: - it renders the neurostimulator compatible with magnetic resonance imaging (MRI) diagnosis - it provides a highly tunable stimulation and ultra low power consumption - it improves safety due to electrical isolation and allow for a smaller size implant
The main objective of this feasibility study is to complete the business plan by: - completing a market study and refining specifications of the neurostimulator with key opinion leaders in the field of epilepsy; - manufacturing prototypes of neurostimulators to validate stimulation capabilities, low power consumption, compactness, optical chain efficiency and estimate production costs; - refining the development and production planning, including budget and human resources, based on cost estimates and test results; - finalizing the selection of subcontractors involved in the production chain; - filing additional patents and realizing a complete FTO.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "NAOS" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "NAOS" are provided by the European Opendata Portal: CORDIS opendata.
More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)
VINOQUANT11SUPERPLUS (2019)
A digital based system for measuring, showing and regulation of the complexe system of wine feremtation with high precision via a Bluetooth -Refractometer, a Software and a Bluetooth Thermostat
Read More